SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 2435.92 millions rose by 48.90% from Rs. 1635.96 millions.The Total Profit for the quarter ended September 2024 of Rs. 376.78 millions grew from Rs.-209.56 millionsOperating profit for the quarter ended September 2024 rose to 567.09 millions as compared to 198.82 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2435.92 1635.96 48.90 4147.29 3059.47 35.56 6875.83 6167.34 11.49
Other Income 85.78 12.59 581.33 104.75 23.61 343.67 137.86 43.20 219.12
PBIDT 567.09 198.82 185.23 849.05 463.45 83.20 1214.53 1269.82 -4.35
Interest 4.94 7.73 -36.09 48.67 12.82 279.64 58.94 24.14 144.16
PBDT 562.15 -126.45 -544.56 800.38 133.09 501.38 838.05 1245.68 -32.72
Depreciation 61.96 34.03 82.07 118.17 68.28 73.07 146.94 123.42 19.06
PBT 500.19 -160.48 -411.68 682.21 64.81 952.63 691.11 1122.26 -38.42
TAX 123.41 49.08 151.45 168.26 105.77 59.08 254.25 288.82 -11.97
Deferred Tax 4.89 6.54 -25.23 13.56 9.85 37.66 45.12 25.05 80.12
PAT 376.78 -209.56 -279.80 513.95 -40.96 -1354.76 436.86 833.44 -47.58
Equity 409.28 368.81 10.97 409.28 368.81 10.97 368.81 364.37 1.22
PBIDTM(%) 23.28 12.15 91.56 20.47 15.15 35.15 17.66 20.59 -14.21

Acutaas Chemicals Share Price

2363.65 42.70 (1.84%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×